Free Trial

Stephanie Davis Analyst Performance

Analyst at Barclays

Stephanie Davis is a stock analyst at Barclays across a range of sectors, covering 17 publicly traded companies. Over the past year, Stephanie Davis has issued 5 stock ratings, including buy and hold recommendations. While full access to Stephanie Davis' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Stephanie Davis' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
39 Last 10 Years
Buy Recommendations
76.92% 30 Buy Ratings
Companies Covered
17 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy76.9%30 ratings
Hold23.1%9 ratings
Sell0.0%0 ratings

Out of 39 total stock ratings issued by Stephanie Davis at Barclays, the majority (76.9%) have been Buy recommendations, followed by 23.1% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
58.8% of companies on NASDAQ
10 companies
NYSE
41.2% of companies on NYSE
7 companies

Stephanie Davis, an analyst at Barclays, currently covers 17 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
10 companies
58.8%
Computer and Technology
4 companies
23.5%
Miscellaneous
2 companies
11.8%
Business Services
1 company
5.9%

Stephanie Davis of Barclays specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and companies.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
4 companies
23.5%
INTERNET SOFTWARE
3 companies
17.6%
MEDICAL INFO SYS
2 companies
11.8%
COMPUTER INTEGRATED SYSTEMS DESIGN
2 companies
11.8%
MED - OUTP/HM CRE
1 company
5.9%
COMPUTER PROGRAMMING, DATA PROCESSING, & OTHER COMPUTER RELATED
1 company
5.9%
COMMUNICATION EQUIPMENT
1 company
5.9%
HOLDING & OTHER INVESTMENT OFFICES
1 company
5.9%
HEALTH INFORMATION SERVICES
1 company
5.9%
Miscellaneous
1 company
5.9%

Stephanie Davis' Ratings History at Barclays

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4/23/2025Boost Price Target$172.56$185.00Equal Weight
Waystar Holding Corp. stock logo
WAY
Waystar
4/14/2025Lower Price Target$36.58$45.00Overweight
Waystar Holding Corp. stock logo
WAY
Waystar
2/19/2025Boost Price Target$45.11$50.00Overweight
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
1/31/2025Boost Price Target$163.97$175.00Equal Weight